Omics methods predict the prognosis and treatment efficacy of chronic obstructive pulmonary disease

Yan Huang,Juanjuan Xu,Guanzhou Ma,Sufei Wang,Xiaojuan Yan,Yang Jin,Jiafu He
DOI: https://doi.org/10.1097/cm9.0000000000002929
IF: 6.133
2024-02-06
Chinese Medical Journal
Abstract:To the Editor : Chronic obstructive pulmonary disease (COPD) is a condition that severely endangers human health. In 2018, Wang et al [ 1 ] reported that there are approximately 100 million patients with COPD in China, with a 13.7% prevalence in people aged over 40 years. The disease severity, frequency of exacerbations, and comorbidities, which are commonly (30–57%) observed in patients with COPD, are the three most crucial elements affecting the economic and societal consequences of COPD. [ 2 ] Hospitalizations for exacerbations are the main contributors to health care expenses. To reduce the clinical and financial burden of COPD, interventions are needed to slow the disease course, avoid exacerbations, and reduce comorbidities, such as approaches for improving the prognosis and treatment efficacy in COPD. Advances in high-throughput omics technology have revolutionized disease research. We gathered data regarding omics methods in the field of COPD research. Genomics, transcriptomics, single-cell transcriptome analysis, proteomics, metabolomics, microbiomics, radiomics, and pharmacogenomics studies were obtained from the PubMed database. Our findings revealed the factors related to COPD prognosis and treatment efficacy by using omics data with predictive potential [Supplementary Figure 1, https://links.lww.com/CM9/B913 ]. Omics may constitute a powerful tool for monitoring COPD prognosis, providing hope for future individualized treatment.
medicine, general & internal
What problem does this paper attempt to address?